LMH STRATEGIC SOLUTIONS

Lobbying for TRAVERE THERAPEUTICS, INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · $20,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Monitored Most-Favored Nation (MFN) and international reference pricing proposals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem